澳大利亚普通人群中的性取向以及酒精和其他药物使用情况。

Sexual identity and prevalence of alcohol and other drug use among Australians in the general population.

作者信息

Roxburgh Amanda, Lea Toby, de Wit John, Degenhardt Louisa

机构信息

National Drug and Alcohol Research Centre (NDARC), University of New South Wales, Sydney, NSW 2052, Australia.

Centre for Social Research in Health, University of New South Wales, Sydney, NSW 2052, Australia.

出版信息

Int J Drug Policy. 2016 Feb;28:76-82. doi: 10.1016/j.drugpo.2015.11.005. Epub 2015 Nov 21.

Abstract

BACKGROUND

International research assessing differences in the prevalence of alcohol and other drug (AOD) use among Lesbian Gay Bisexual and Transgender (LGBTI) and heterosexual populations shows elevated prevalence rates of substance use among LGBTI people. To date no research has been published investigating these differences at a population level among both men and women in Australia.

METHODS

The 2013 National Drug Strategy Household Survey, a multistage stratified population sample collecting data on AOD use in the Australian population over 14 years of age, was analysed for differences between gay and bisexual (GB) men and lesbian/gay and bisexual (LGB) women and their heterosexual counterparts in: (1) the prevalence of lifetime and past year tobacco and AOD use; (2) age of initiation of tobacco and AOD use; and (3) frequency of alcohol and cannabis use, and history of AOD treatment.

RESULTS

There were elevated rates of past year cannabis (22.4%), ecstasy (11.8%) and methamphetamine (9.7%) use among GB men compared to heterosexual men (12.4%, 2.9% and 2.5%). LGB women also reported elevated rates of past year use (tobacco - 23.7%; cannabis - 24.6%) compared to heterosexual women (10.6% and 7.1%). LGB women initiated tobacco (15.2 years) and alcohol (15.5 years) at an earlier age than heterosexual women (16.6 and 17.7 years), and were significantly more likely to report daily alcohol consumption (OR 3.2, 95% CI: 2.1, 5.1), and weekly or more frequent cannabis use (OR 1.7, 95%CI: 1.1, 3.1).

CONCLUSIONS

These findings are indicative of the need for more responsive and targeted AOD harm reduction and treatment services for LGBTI communities in Australia. Of concern is the elevated risk among LGB women for earlier initiation of substance use, and the development of problematic consumption patterns. Further research, investigating the risk and protective factors for AOD use among LGB women is warranted.

摘要

背景

一项国际研究评估了女同性恋、男同性恋、双性恋和跨性别者(LGBTI)与异性恋人群在酒精及其他药物(AOD)使用患病率上的差异,结果显示LGBTI人群中物质使用的患病率较高。迄今为止,尚无研究发表,探讨澳大利亚男性和女性在人群层面上的这些差异。

方法

对2013年全国药物战略家庭调查进行分析,该调查采用多阶段分层抽样,收集澳大利亚14岁以上人群的AOD使用数据,以比较男同性恋和双性恋(GB)男性、女同性恋/男同性恋和双性恋(LGB)女性与异性恋对应人群在以下方面的差异:(1)终生及过去一年烟草和AOD使用的患病率;(2)开始使用烟草和AOD的年龄;(3)酒精和大麻的使用频率以及AOD治疗史。

结果

与异性恋男性(分别为12.4%、2.9%和2.5%)相比,GB男性过去一年大麻(22.4%)、摇头丸(11.8%)和甲基苯丙胺(9.7%)的使用率较高。与异性恋女性(分别为10.6%和7.1%)相比,LGB女性过去一年的使用率(烟草 - 23.7%;大麻 - 24.6%)也较高。LGB女性开始使用烟草(15.2岁)和酒精(15.5岁)的年龄早于异性恋女性(16.6岁和17.7岁),并且更有可能报告每日饮酒(比值比3.2,95%置信区间:2.1,5.1)以及每周或更频繁使用大麻(比值比1.7,95%置信区间:1.1,3.1)。

结论

这些发现表明,澳大利亚需要为LGBTI社区提供更具针对性和响应性的AOD危害减少及治疗服务。令人担忧的是,LGB女性更早开始使用物质以及出现问题消费模式的风险升高。有必要进一步开展研究,调查LGB女性AOD使用的风险和保护因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索